![[fetch_key]](https://stocktradeupdates.com/wp-content/uploads/new_logos/JHS.png)
Share the post "JHS Svendgaard Laboratories ‘s Q2 Report: Revenue Rises by 3.96% YoY"
Highlights
- The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 3.96 % in the past year, decrease in net sales/revenue by -19.62 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 341.54 %. Marginal increase in other income during this quarter, up by 169.06%.
- Profit over the Year and quarter: Significant improvement in profitability for JHS Svendgaard Laboratories Limited. Notable increase of 1313.56 % in net profit Year to Year, JHS Svendgaard Laboratories Limited’s profitability increased by 1540.54 % in this quarter.
- EPS over the Year and quarter: EPS increased by 1,277.78 % Year to Year. EPS increased by 1450 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 18.931 Cr | Rs. 24.484 Cr | Rs. 19.681 Cr | -19.62 % | + 3.96 % |
| Expenses | Rs. 18.52 Cr | Rs. 22.51 Cr | Rs. 20.52 Cr | -8.84 % | + 10.8 % |
| Operating Profit | Rs. 0.41 Cr | Rs. 1.97 Cr | Rs. -0.84 Cr | -142.64 % | -304.88 % |
| OPM % | 2.17 % | 8.05 % | -4.27 % | -12.32 % | -6.44 % |
| Other Income | Rs. 0.195 Cr | Rs. 0.32 Cr | Rs. 0.861 Cr | + 169.06 % | + 341.54 % |
| Interest | Rs. 0.1 Cr | Rs. 0.12 Cr | Rs. 0.11 Cr | -8.33 % | + 10 % |
| Depreciation | Rs. 1.5 Cr | Rs. 1.97 Cr | Rs. 1.98 Cr | + 0.51 % | + 32 % |
| Profit before tax | Rs. -1 Cr | Rs. 0.2 Cr | Rs. -2.07 Cr | -1135 % | -107 % |
| Tax % | -26.56 % | 416.08 % | -397.78 % | -813.86 % | -371.22 % |
| Net Profit | Rs. -0.73 Cr | Rs. -0.63 Cr | Rs. -10.32 Cr | -1538.1 % | -1313.7 % |
| EPS in Rs | Rs. -0.09 | Rs. -0.08 | Rs. -1.24 | -1450 % | -1277.78 % |
Today, we’re looking at JHS Svendgaard Laboratories Limited’s financial performance for the Q2(Sep 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 3.96 %. However, it did see a marginal slip of -19.62 % from the previous quarter. Expenses decreased slightly by -8.84 % quarter-on-quarter, aligning with the annual rise of 10.8 %. Operating profit, while down -304.88 % compared to last year, faced a quarter-on-quarter dip of -142.64 %, signaling a short-term contraction in margins.
The Operating Profit Margin (OPM) % contradicts this narrative, showing weakness on an annual basis with a decrease of -6.44 %, but a shrinkage of -12.32 % sequentially. Other income rose by 169.06 % compared to the last quarter, despite an annual growth of 341.54 %. Interest expenses dropped significantly by -8.33 % from the previous quarter, yet the year-over-year increase remains at a moderate 10 %. Depreciation costs climbed by 0.51 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 32 %. Profit before tax declined annually by -107 % but saw a reduction from the preceding quarter by -1135 %.
Tax expenses as a percentage of profits decreased slightly by -371.22 % compared to last year, with a more notable quarter-on-quarter decrease of -813.86 %. Net profit fell by -1313.7 % year-on-year but witnessed a -1538.1 % contraction from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual downturn of -1277.78 % but a quarterly fall of -1450 %. In summary, JHS Svendgaard Laboratories Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 18.931 Cr | Rs. 24.484 Cr | Rs. 19.681 Cr | -19.62 % | + 3.96 % |
| Expenses | Rs. 18.52 Cr | Rs. 22.51 Cr | Rs. 20.52 Cr | -8.84 % | + 10.8 % |
| Operating Profit | Rs. 0.41 Cr | Rs. 1.97 Cr | Rs. -0.84 Cr | -142.64 % | -304.88 % |
| Net Profit | Rs. -0.73 Cr | Rs. -0.63 Cr | Rs. -10.32 Cr | -1538.1 % | -1313.7 % |
| EPS in Rs | Rs. -0.09 | Rs. -0.08 | Rs. -1.24 | -1450 % | -1277.78 % |
In reviewing JHS Svendgaard Laboratories Limited’s 2024-25(Q2) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 3.96 % year-on-year growth, although there was a slight dip of -19.62 % from the previous quarter. Expenses rose by 10.8 % compared to the previous year, with a decrease of -8.84 % quarter-on-quarter. Operating Profit dropped by -304.88 % annually, and saw a -142.64 % decrease from the last quarter.
Net Profit showed yearly decrease of -1313.7 %, and experienced a -1538.1 % decrease from the previous quarter. Earnings Per Share (EPS) fell by -1277.78 % annually, however dipped by -1450 % compared to the last quarter. In essence, while JHS Svendgaard Laboratories Limited faces strong annual decline indicators, short-term fluctuations suggest the need for agile strategies to navigate market dynamics effectively. That’s all for now in the financial sector.
[my_shortcode1 values=”JHS Svendgaard Laboratories Limited”]
